STOCK TITAN

Dror Ortho-Design SEC Filings

DROR OTC

Welcome to our dedicated page for Dror Ortho-Design SEC filings (Ticker: DROR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Dror Ortho-Design, Inc. (DROR) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory documents, offering insight into its orthodontic platform business and capital structure. As an AI-based orthodontic company developing the ZSmile smart aligner system, Dror uses SEC reports to describe its financing arrangements, reporting status, and registration activities.

Investors can review Current Reports on Form 8-K in which Dror details private placements of debentures and related warrants. These filings explain the principal amounts, maturity dates, conversion features tied to potential public offerings, and limitations on ownership percentages. They also describe the exemptions from registration under the Securities Act of 1933 that the company relies on for these transactions.

The filings page may also include registration statements such as Form S-1 and associated prospectus references, where Dror outlines the securities registered and background information about its AI-based orthodontic platform and ZSmile technology. Notifications of late filing, such as Form 12b-25 (NT 10-Q), provide context when the company requires additional time to complete and finalize its financial statements.

Through Stock Titan, users can access these DROR filings alongside AI-powered summaries that highlight key terms, structural features of debentures and warrants, and important dates. This helps readers quickly understand how Dror funds the development and commercialization of its ZSmile platform, how its reporting obligations are being met, and what regulatory steps it has taken in the U.S. capital markets.

Rhea-AI Summary

Dror Ortho-Design, Inc. entered into a Securities Purchase Agreement for a private placement of Debentures with an aggregate principal amount of $250,000, which closed on December 30, 2025. The Debentures bear 0% interest and mature on February 28, 2026, with holders able to extend maturity in 60-day increments. If the company completes a public offering before maturity, the outstanding principal will automatically convert into common stock at the same per-share price used in that offering, and the resulting shares will carry the same terms as those sold in the offering.

Subject to completion of a public offering, investors are also entitled to receive Warrants to buy common stock at the public offering price, expiring five years from issuance, with customary anti-dilution and price-based adjustments. Both the Debentures and any Warrants include a 9.99% beneficial ownership cap, limiting how much equity any holder can acquire through conversion or exercise. The transaction was conducted as an unregistered offering under Section 4(a)(2) and Regulation D, with all purchasers represented as accredited investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Dror Ortho-Design, Inc. entered into a Securities Purchase Agreement for a private placement of 0% debentures with an aggregate principal amount of $200,000, maturing on February 2, 2026. If the company completes a public offering before maturity, the outstanding debentures will automatically convert into common shares at the public offering share price, with those shares carrying the same terms and any accompanying warrants and registration rights as in the offering.

Subject to the completion of that public offering, investors are also entitled to warrants for additional common shares, with quantities tied to the number of debenture conversion shares and a defined “warrant subscription amount.” Any warrants issued will be immediately exercisable at the public offering price and will expire five years after issuance. Both debenture conversions and warrant exercises are capped so that a holder cannot beneficially own more than 9.99% of outstanding common stock. The transaction was conducted as an unregistered private placement under Section 4(a)(2) and Regulation D.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Dror Ortho-Design, Inc., a pre-revenue Israeli orthodontic device developer, reported a net loss of $653,528 for the quarter and $1,988,989 for the nine months ended September 30, 2025, narrower than a year ago as research and development and share-based compensation declined.

Cash fell to $240,362 with total assets of $271,218, while current liabilities reached $2,420,477, resulting in a stockholders’ deficit of $2,317,813. Management states there is substantial doubt about the company’s ability to continue as a going concern and it remains dependent on external financing.

During the first nine months of 2025 Dror raised $1,100,000 via zero-interest convertible debentures that may convert into common shares in a future public offering and created a derivative warrant liability of $478,285. The company continues developing its AI-based, sleep-time orthodontic alignment platform and plans to seek new FDA 510(k) clearance for this updated device.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

Dror Ortho-Design, Inc. has filed a Form 12b-25 to notify the SEC and investors that its Quarterly Report on Form 10-Q for the nine months ended September 30, 2025 will be filed late. The company states it cannot meet the original deadline without unreasonable effort and expense because it needs more time to complete and finalize the financial statements required in the report.

The company indicates that it currently anticipates filing the Form 10-Q on or before the fifth calendar day following the prescribed due date, consistent with the timing relief available under Rule 12b-25 for quarterly reports.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Dror Ortho-Design (DROR)?

The current stock price of Dror Ortho-Design (DROR) is $0.007 as of January 23, 2026.

What is the market cap of Dror Ortho-Design (DROR)?

The market cap of Dror Ortho-Design (DROR) is approximately 28.7M.
Dror Ortho-Design

OTC:DROR

DROR Rankings

DROR Stock Data

28.71M
601.46M
28.28%
10%
Personal Services
Consumer Cyclical
Link
Israel
Jerusalem

DROR RSS Feed